Introduction Branhamella (previously Neisseria) catarrhalis is an aerobic Gram negative diplococcus. It has generally been regarded as an oropharyngeal commensal, though it has been implicated as a pathogen in sinusitis, laryngitis, otitis media, meningitis, and endocarditis. In the past decade it has been shown to cause pneumonia in immunologically compromised patients' and infective exacerbations in patients with chronic lung disease. 2 Recently, an increasing number of strains producing r-lactamase have been described.' In spite of this, the number of reports of respiratory disease due to B catarrhalis has been relatively small.4 We have always reported the presence of pure growths of B catarrhalis in sputum samples, and we noted a striking increase in the number of such isolates during the past winter months, many being the only organism found in the sputum of seriously ill patients. This, together with a notable increase in the proportion of strains producing 3-lactamase, caused us to review the antibiotic policy of our acute respiratory wards. In the belief that others will soon see this changing pattern of pathogens we report the clinical features of B catarrhalis infection.
Methods
Our bacteriology laboratory receives sputum samples from hospital wards, outpatient departments, and local general practices. A purulent part of each sputum specimen received was examined with a Gram film and inoculated on blood agar and heated blood plates (containing bacitracin 10 units/ml Of the 38 patients who acquired the infection in the community, 24 had B catarrhalis in their sputum on admission to hospital; 12 were attending hospital outpatient departments, and two were attending general practices. Among these 38 patients 17 had strains that produced P-lactamase; 12 of these 17 had been treated unsuccessfully with ampicillin. Forty three patients became infected in hospital, and in 24 of these the sputum contained strains producing P-lactamase. In January 64% of all the strains produced 3-lactamase.
All the isolates were sensitive to chloramphenicol, erythromycin, and co-trimoxazole. A retrospective study of 50 strains of B catarrhalis (stored at -70°C) showed that all were sensitive to clavulanic acid and amoxycillin (Augmentin) and to cefuroxime but resistant to trimethoprim. 
Discussion
Most strains of B catarrhalis are commensals, but well documented reports confirm that some are potential pathogens, and latterly attention has been drawn to their capacity for producing 3-lactamase.' This r-lactamase has minimal cephalosporinase activity and is inactivated by clavulinic acid.,8 Its production is due to a chromosomal determinant, is not plasmid associated, and is therefore not transferable.3 Our bacteriology laboratory has always reported B catarrhalis in sputum as a potential pathogen when there are numerous pus cells with extraleucocyte and intraleucocyte Gram negative diplococci, a moderate or profuse growth of B catarrhalis, and no other known respiratory pathogens. The results from culture together with the Gram film assist greatly in the clinical assessment of whether antibiotic treatment should be started. Transtracheal aspiration of sputum to prevent oropharyngeal contamination is uncomfortable and, in our experience, unnecessary.9
Initially, we ignored reports of B catarrhalis until it became apparent that patients' symptoms did not respond to ampicillin and that no other pathogens had been isolated. Moreover, patients admitted with B catarrhalis infection had usually not responded to a course of ampicillin but were soon better with erythromycin or co-trimoxazole. More disturbing was the development of purulent sputum in inpatients already taking ampicillin, from whom strain's of B catarrhalis producing f-lactamase were almost inevitably isolated. This striking increase in the incidence of isolation of B catarrhalis is partly explained by the high proportion of patients who became infected on the wards, a feature of B catarrhalis infection not previously documented. There was also an unexplained increase in the community, which perhaps may be due to local changes in antibiotic prescribing habits in general practice and hospital practice leading to the growth of resistant, more virulent strains. The true incidence of B catarrhalis is unknown but is probably underreported. In our experience the concurrence of other pathogenic bacteria such as H influenzae or S pneumoniae with B catarrhalis is uncommon. As B catarrhalis is a potential pulmonary pathogen capable of producing 3-lactamase it should be reported both in pure culture and when mixed with other pathogens, as not only may an inappropriate antibiotic be prescribed but the 3-lactamase may protect the other pathogenic bacteria from the action of ampicillin. A 53 year old woman has a 10 year history of the sicca syndrome-dry mouth and minimal dryness of the eyes-but no other part of the body is affected. In the past year she has had three attacks of parotitis affecting both parotic glands and associated with a high fever and exacerbation of the dryness of the mouth. This has gradually responded to either penicillin or a tetracycline. Can a further attack be prevented ? Is there any treatment to encourage the flow of saliva to relieve dryness of the mouth ?
Sicca syndrome is a widespread clinical problem, most frequently recognised as dryness or irritation in the eyes but also affecting other mucus producing surfaces in the body, including the mouth (leading to dental caries and difficulty in swallowing), trachea and larynx, oesophagus, vagina, and bronchial tree. Although the dry eyes are usually helped by methyl-cellulose eye drops ("artificial tears"), treatment of the dry mouth is at best unsatisfactory. Of all the sialogogues advocated, none is wholly satisfactory. Pure lemon juice is worth trying, if only because of convenience. In severe cases parotid dryness leads to recurrent infection and sialectasis. Little can be done to prevent attacks other than to maintain adequate hydration and oral hygiene-especially when surgery is carried out. Parotid calculi may require surgery. Sicca syndrome is also a feature of about 30°' of patients with various connective tissue diseases such as rheumatoid arthritis. Furthermore, it may be the only clinical feature of these diseases, manifest, for example, in relatives of patients with connective tissue diseases or subclinically as hyperglobinaemia, raised erythrocyte sedimentation rate, positive rheumatoid factor, anaemia, or leucopenia. The risks of such individuals developing more serious disease are not clearly known, and it is doubtful whether treatment at this stage would be beneficial-GRAHAM R V HUGHES, consultant physician and reader in rheumatology, London.
